A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform - PubMed (original) (raw)
. 2010 Dec;127(1-3):332-6.
doi: 10.1016/j.jad.2010.05.019. Epub 2010 Jun 25.
Affiliations
- PMID: 20579744
- DOI: 10.1016/j.jad.2010.05.019
A polymorphism in the microRNA-30e precursor associated with major depressive disorder risk and P300 waveform
Yong Xu et al. J Affect Disord. 2010 Dec.
Abstract
Background: Growing evidence shows that the etiological causes and pathological processes underlying major depressive disorder (MDD) and schizophrenia (SCZ) overlap. Our previous study revealed a strong association between the polymorphism ss178077483 in the miRNA-30e precursor (pre-miR-30e) and the risk of SCZ. We thus hypothesized that this SCZ risk allele at the pre-miR-30e gene also confers risk of MDD.
Methods: To explore the relationship between miR-30e ss178077483 and MDD, we conducted an association analyses in 1088 MDD patients and 1102 control subjects from the Han Chinese population. We also determined the effects of miR-30e ss178077483 on the development of P300 event-related potential components induced by an auditory odd-ball task.
Results: We detected a statistically significant positive association between miR-30e ss178077483 and MDD (allelic P=0.0287; genotypic P=0.0275). Moreover, the P300 latency was associated with miR-30e ss178077483 genotypes and the individuals with the C/T genotype have a longer P300 latency than those carrying the C/C genotype (P=0.009).
Limitations: Larger numbers of subjects and different ethnic groups would confirm and strengthen these preliminary findings.
Conclusions: To our knowledge, this is the first evidence to suggest that miRNA polymorphisms may play an important role in MDD susceptibility. These findings also imply that certain miRNAs may be involved in the etiology of MDD.
Copyright © 2010 Elsevier B.V. All rights reserved.
Similar articles
- MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.
Xu Y, Li F, Zhang B, Zhang K, Zhang F, Huang X, Sun N, Ren Y, Sui M, Liu P. Xu Y, et al. Schizophr Res. 2010 Jun;119(1-3):219-27. doi: 10.1016/j.schres.2010.02.1070. Epub 2010 Mar 27. Schizophr Res. 2010. PMID: 20347265 - Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.
Liu S, Sun N, Xu Y, Yang C, Ren Y, Liu Z, Cao X, Sun Y, Xu Q, Zhang K, Shen Y. Liu S, et al. Genet Test Mol Biomarkers. 2012 Dec;16(12):1382-9. doi: 10.1089/gtmb.2012.0227. Epub 2012 Oct 2. Genet Test Mol Biomarkers. 2012. PMID: 23030648 Free PMC article. - The interaction of miR-34b/c polymorphisms and negative life events increases susceptibility to major depressive disorder in Han Chinese population.
Xu C, Yang C, Zhang A, Xu Y, Li X, Liu Z, Liu S, Sun N, Zhang K. Xu C, et al. Neurosci Lett. 2017 Jun 9;651:65-71. doi: 10.1016/j.neulet.2017.04.061. Epub 2017 Apr 29. Neurosci Lett. 2017. PMID: 28461137 - Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
Postolache TT, Del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C. Postolache TT, et al. Am J Med Genet B Neuropsychiatr Genet. 2019 Apr;180(3):186-203. doi: 10.1002/ajmg.b.32712. Epub 2019 Feb 6. Am J Med Genet B Neuropsychiatr Genet. 2019. PMID: 30729689 Free PMC article. Review. - HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.
Gu L, Long J, Yan Y, Chen Q, Pan R, Xie X, Mao X, Hu X, Wei B, Su L. Gu L, et al. J Neurosci Res. 2013 May;91(5):623-33. doi: 10.1002/jnr.23180. Epub 2013 Feb 13. J Neurosci Res. 2013. PMID: 23404241 Review.
Cited by
- Baseline levels of miR-223-3p correlate with the effectiveness of electroconvulsive therapy in patients with major depression.
Kaurani L, Besse M, Methfessel I, Methi A, Zhou J, Pradhan R, Burkhardt S, Kranaster L, Sartorius A, Habel U, Grözinger M, Fischer A, Wiltfang J, Zilles-Wegner D. Kaurani L, et al. Transl Psychiatry. 2023 Sep 13;13(1):294. doi: 10.1038/s41398-023-02582-4. Transl Psychiatry. 2023. PMID: 37699900 Free PMC article. - Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential.
Yuan M, Yang B, Rothschild G, Mann JJ, Sanford LD, Tang X, Huang C, Wang C, Zhang W. Yuan M, et al. Signal Transduct Target Ther. 2023 Aug 30;8(1):309. doi: 10.1038/s41392-023-01519-z. Signal Transduct Target Ther. 2023. PMID: 37644009 Free PMC article. Review. - MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder.
Stapel B, Xiao K, Gorinski N, Schmidt K, Pfanne A, Fiedler J, Richter I, Vollbrecht AL, Thum T, Kahl KG, Ponimaskin E. Stapel B, et al. Front Psychiatry. 2022 Nov 24;13:1020530. doi: 10.3389/fpsyt.2022.1020530. eCollection 2022. Front Psychiatry. 2022. PMID: 36506422 Free PMC article. - Bipolar-associated miR-499-5p controls neuroplasticity by downregulating the Cav1.2 subunit CACNB2.
Martins HC, Gilardi C, Sungur AÖ, Winterer J, Pelzl MA, Bicker S, Gross F, Kisko TM, Malikowska-Racia N, Braun MD, Brosch K, Nenadic I, Stein F, Meinert S, Schwarting RKW, Dannlowski U, Kircher T, Wöhr M, Schratt G. Martins HC, et al. EMBO Rep. 2022 Oct 6;23(10):e54420. doi: 10.15252/embr.202154420. Epub 2022 Aug 15. EMBO Rep. 2022. PMID: 35969184 Free PMC article. - MicroRNAs as Critical Biomarkers of Major Depressive Disorder: A Comprehensive Perspective.
Ortega MA, Alvarez-Mon MA, García-Montero C, Fraile-Martinez O, Lahera G, Monserrat J, Muñoz-Merida L, Mora F, Rodríguez-Jiménez R, Fernandez-Rojo S, Quintero J, Álvarez-Mon M. Ortega MA, et al. Biomedicines. 2021 Nov 10;9(11):1659. doi: 10.3390/biomedicines9111659. Biomedicines. 2021. PMID: 34829888 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous